Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Expert Review of Neurotherapeutics
|
February 13, 2019
Cariprazine for the treatment of bipolar depression: a review
Renee-Marie Ragguett, Roger S McIntyre
Brain Research Bulletin
|
December 16, 2023
Association between altered white matter networks and post operative ventricle volume in shunt-treated pediatric hydrocephalus
Renee-Marie Ragguett, Roy Eagleson, Sandrine de Ribaupierre
CNS Spectrums
|
June 29, 2019
Keeping up with the clinical advances: depression
Renee-Marie Ragguett, Jocelyn K Tamura, Roger S McIntyre
Frontiers in Neuroscience
|
June 18, 2024
Evaluating normalized registration and preprocessing methodologies for the analysis of brain MRI in pediatric patients with shunt-treated hydrocephalus
Renee-Marie Ragguett, Roy Eagleson, Sandrine de Ribaupierre
CNS Spectrums
|
September 5, 2019
Keeping up with the clinical advances: depression-Addendum
Renee-Marie Ragguett, Jocelyn K Tamura, Roger S McIntyre
Expert Opinion on Investigational Drugs
|
December 27, 2018
Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date
Renee-Marie Ragguett, Carola Rong, Kevin Kratiuk, et al.
Journal of Neurosurgery. Pediatrics
|
May 22, 2026
Hippocampal volume for prediction of working memory performance in patients with infantile hydrocephalus
Renee-Marie Ragguett, Lili Meng, Derya Adil, et al.
Expert Opinion on Pharmacotherapy
|
December 3, 2017
Efficacy of levomilnacipran extended release in treating major depressive disorder
Renee-Marie Ragguett, Samantha J Yim, Peter T Ho, et al.
Human Psychopharmacology
|
October 6, 2017
Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: An updated meta-analysis
Renee-Marie Ragguett, Margaret Hahn, Giovanni Messina, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 7, 2018
Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder
Renee-Marie Ragguett, Carola Rong, Joshua D Rosenblat, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Expert Review of Neurotherapeutics
|
February 13, 2019
Cariprazine for the treatment of bipolar depression: a review
Renee-Marie Ragguett, Roger S McIntyre
Brain Research Bulletin
|
December 16, 2023
Association between altered white matter networks and post operative ventricle volume in shunt-treated pediatric hydrocephalus
Renee-Marie Ragguett, Roy Eagleson, Sandrine de Ribaupierre
CNS Spectrums
|
June 29, 2019
Keeping up with the clinical advances: depression
Renee-Marie Ragguett, Jocelyn K Tamura, Roger S McIntyre
Frontiers in Neuroscience
|
June 18, 2024
Evaluating normalized registration and preprocessing methodologies for the analysis of brain MRI in pediatric patients with shunt-treated hydrocephalus
Renee-Marie Ragguett, Roy Eagleson, Sandrine de Ribaupierre
CNS Spectrums
|
September 5, 2019
Keeping up with the clinical advances: depression-Addendum
Renee-Marie Ragguett, Jocelyn K Tamura, Roger S McIntyre
Expert Opinion on Investigational Drugs
|
December 27, 2018
Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date
Renee-Marie Ragguett, Carola Rong, Kevin Kratiuk, et al.
Journal of Neurosurgery. Pediatrics
|
May 22, 2026
Hippocampal volume for prediction of working memory performance in patients with infantile hydrocephalus
Renee-Marie Ragguett, Lili Meng, Derya Adil, et al.
Expert Opinion on Pharmacotherapy
|
December 3, 2017
Efficacy of levomilnacipran extended release in treating major depressive disorder
Renee-Marie Ragguett, Samantha J Yim, Peter T Ho, et al.
Human Psychopharmacology
|
October 6, 2017
Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: An updated meta-analysis
Renee-Marie Ragguett, Margaret Hahn, Giovanni Messina, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
April 7, 2018
Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder
Renee-Marie Ragguett, Carola Rong, Joshua D Rosenblat, et al.
Page
of 3